Clearview Wealth Advisors’s Nu Skin NUS Stock Holding History

Clearview Wealth Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,962	Closed	-$275K	–	126
2023 Q3	$275K	Buy	+12,962	New	+$337K	0.34%	96

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clearview Wealth Advisors's NUS Position: Q4 2023 in Review

Clearview Wealth Advisors sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 12,962 shares — an estimated $275K sold.

Clearview Wealth Advisors first reported a position in NUS in Q3 2023 and held it in 1 quarter. The position peaked at $275K in Q3 2023. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.

Clearview Wealth Advisors reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
Clearview Wealth Advisors sold 12,962 Nu Skin shares in Q4 2023, an estimated $275K.
Clearview Wealth Advisors first reported a position in Nu Skin in Q3 2023 and held it in 1 quarter.
Clearview Wealth Advisors's Nu Skin position peaked at $275K in Q3 2023.
212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.

Based on Clearview Wealth Advisors's 13F filing for Q4 2023, filed 12 Jan 2024.